The antiapoptotic protein Bcl-xL negatively regulates the bone-resorbing activity of osteoclasts in mice

Mitsuyasu Iwasawa, Tsuyoshi Miyazaki, Yuichi Nagase, Toru Akiyama, Yuho Kadono, Masaki Nakamura, Yasushi Oshima, Tetsuro Yasui, Takumi Matsumoto, Takashi Nakamura, Shigeaki Kato, Lothar Hennighausen, Kozo Nakamura, Sakae Tanaka

Research output: Contribution to journalArticle

29 Citations (Scopus)

Abstract

The B cell lymphoma 2 (Bcl-2) family member Bcl-xL has a well-characterized antiapoptotic function in lymphoid cells. However, its functions in other cells - including osteoclasts, which are of hematopoietic origin - and other cellular processes remain unknown. Here we report an unexpected function of Bcl-xL in attenuating the bone-resorbing activity of osteoclasts in mice. To investigate the role of Bcl-xL in osteoclasts, we generated mice with osteoclast-specific conditional deletion of Bcl-x (referred to herein as Bcl-x cKO mice) by mating Bcl-xfl/fl mice with mice in which the gene encoding the Cre recombinase has been knocked into the cathepsin K locus and specifically expressed in mature osteoclasts. Although the Bcl-x cKO mice grew normally with no apparent morphological abnormalities, they developed substantial osteopenia at 1 year of age, which was caused by increased bone resorption. Bcl-x deficiency increased the bone-resorbing activity of osteoclasts despite their high susceptibility to apoptosis, whereas Bcl-xL overexpression produced the opposite effect. In addition, Bcl-x cKO osteoclasts displayed increased c-Src activity, which was linked to increased levels of vitronectin and fibronectin expression. These results suggest that Bcl-xL attenuates osteoclastic bone-resorbing activity through the decreased production of ECM proteins, such as vitronectin and fibronectin, and thus provide evidence for what we believe to be a novel cellular function of Bcl-xL.

Original languageEnglish
Pages (from-to)3149-3159
Number of pages11
JournalJournal of Clinical Investigation
Volume119
Issue number10
DOIs
Publication statusPublished - 2009 Oct 1
Externally publishedYes

Fingerprint

Osteoclasts
Proteins
Vitronectin
Fibronectins
Cathepsin K
Metabolic Bone Diseases
B-Cell Lymphoma
Bone Resorption
bone resorption factor
Lymphocytes
Apoptosis
Genes

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Iwasawa, M., Miyazaki, T., Nagase, Y., Akiyama, T., Kadono, Y., Nakamura, M., ... Tanaka, S. (2009). The antiapoptotic protein Bcl-xL negatively regulates the bone-resorbing activity of osteoclasts in mice. Journal of Clinical Investigation, 119(10), 3149-3159. https://doi.org/10.1172/JCI39819

The antiapoptotic protein Bcl-xL negatively regulates the bone-resorbing activity of osteoclasts in mice. / Iwasawa, Mitsuyasu; Miyazaki, Tsuyoshi; Nagase, Yuichi; Akiyama, Toru; Kadono, Yuho; Nakamura, Masaki; Oshima, Yasushi; Yasui, Tetsuro; Matsumoto, Takumi; Nakamura, Takashi; Kato, Shigeaki; Hennighausen, Lothar; Nakamura, Kozo; Tanaka, Sakae.

In: Journal of Clinical Investigation, Vol. 119, No. 10, 01.10.2009, p. 3149-3159.

Research output: Contribution to journalArticle

Iwasawa, M, Miyazaki, T, Nagase, Y, Akiyama, T, Kadono, Y, Nakamura, M, Oshima, Y, Yasui, T, Matsumoto, T, Nakamura, T, Kato, S, Hennighausen, L, Nakamura, K & Tanaka, S 2009, 'The antiapoptotic protein Bcl-xL negatively regulates the bone-resorbing activity of osteoclasts in mice', Journal of Clinical Investigation, vol. 119, no. 10, pp. 3149-3159. https://doi.org/10.1172/JCI39819
Iwasawa, Mitsuyasu ; Miyazaki, Tsuyoshi ; Nagase, Yuichi ; Akiyama, Toru ; Kadono, Yuho ; Nakamura, Masaki ; Oshima, Yasushi ; Yasui, Tetsuro ; Matsumoto, Takumi ; Nakamura, Takashi ; Kato, Shigeaki ; Hennighausen, Lothar ; Nakamura, Kozo ; Tanaka, Sakae. / The antiapoptotic protein Bcl-xL negatively regulates the bone-resorbing activity of osteoclasts in mice. In: Journal of Clinical Investigation. 2009 ; Vol. 119, No. 10. pp. 3149-3159.
@article{738a0e49bdb14f71be389d048fcf8416,
title = "The antiapoptotic protein Bcl-xL negatively regulates the bone-resorbing activity of osteoclasts in mice",
abstract = "The B cell lymphoma 2 (Bcl-2) family member Bcl-xL has a well-characterized antiapoptotic function in lymphoid cells. However, its functions in other cells - including osteoclasts, which are of hematopoietic origin - and other cellular processes remain unknown. Here we report an unexpected function of Bcl-xL in attenuating the bone-resorbing activity of osteoclasts in mice. To investigate the role of Bcl-xL in osteoclasts, we generated mice with osteoclast-specific conditional deletion of Bcl-x (referred to herein as Bcl-x cKO mice) by mating Bcl-xfl/fl mice with mice in which the gene encoding the Cre recombinase has been knocked into the cathepsin K locus and specifically expressed in mature osteoclasts. Although the Bcl-x cKO mice grew normally with no apparent morphological abnormalities, they developed substantial osteopenia at 1 year of age, which was caused by increased bone resorption. Bcl-x deficiency increased the bone-resorbing activity of osteoclasts despite their high susceptibility to apoptosis, whereas Bcl-xL overexpression produced the opposite effect. In addition, Bcl-x cKO osteoclasts displayed increased c-Src activity, which was linked to increased levels of vitronectin and fibronectin expression. These results suggest that Bcl-xL attenuates osteoclastic bone-resorbing activity through the decreased production of ECM proteins, such as vitronectin and fibronectin, and thus provide evidence for what we believe to be a novel cellular function of Bcl-xL.",
author = "Mitsuyasu Iwasawa and Tsuyoshi Miyazaki and Yuichi Nagase and Toru Akiyama and Yuho Kadono and Masaki Nakamura and Yasushi Oshima and Tetsuro Yasui and Takumi Matsumoto and Takashi Nakamura and Shigeaki Kato and Lothar Hennighausen and Kozo Nakamura and Sakae Tanaka",
year = "2009",
month = "10",
day = "1",
doi = "10.1172/JCI39819",
language = "English",
volume = "119",
pages = "3149--3159",
journal = "Journal of Clinical Investigation",
issn = "0021-9738",
publisher = "The American Society for Clinical Investigation",
number = "10",

}

TY - JOUR

T1 - The antiapoptotic protein Bcl-xL negatively regulates the bone-resorbing activity of osteoclasts in mice

AU - Iwasawa, Mitsuyasu

AU - Miyazaki, Tsuyoshi

AU - Nagase, Yuichi

AU - Akiyama, Toru

AU - Kadono, Yuho

AU - Nakamura, Masaki

AU - Oshima, Yasushi

AU - Yasui, Tetsuro

AU - Matsumoto, Takumi

AU - Nakamura, Takashi

AU - Kato, Shigeaki

AU - Hennighausen, Lothar

AU - Nakamura, Kozo

AU - Tanaka, Sakae

PY - 2009/10/1

Y1 - 2009/10/1

N2 - The B cell lymphoma 2 (Bcl-2) family member Bcl-xL has a well-characterized antiapoptotic function in lymphoid cells. However, its functions in other cells - including osteoclasts, which are of hematopoietic origin - and other cellular processes remain unknown. Here we report an unexpected function of Bcl-xL in attenuating the bone-resorbing activity of osteoclasts in mice. To investigate the role of Bcl-xL in osteoclasts, we generated mice with osteoclast-specific conditional deletion of Bcl-x (referred to herein as Bcl-x cKO mice) by mating Bcl-xfl/fl mice with mice in which the gene encoding the Cre recombinase has been knocked into the cathepsin K locus and specifically expressed in mature osteoclasts. Although the Bcl-x cKO mice grew normally with no apparent morphological abnormalities, they developed substantial osteopenia at 1 year of age, which was caused by increased bone resorption. Bcl-x deficiency increased the bone-resorbing activity of osteoclasts despite their high susceptibility to apoptosis, whereas Bcl-xL overexpression produced the opposite effect. In addition, Bcl-x cKO osteoclasts displayed increased c-Src activity, which was linked to increased levels of vitronectin and fibronectin expression. These results suggest that Bcl-xL attenuates osteoclastic bone-resorbing activity through the decreased production of ECM proteins, such as vitronectin and fibronectin, and thus provide evidence for what we believe to be a novel cellular function of Bcl-xL.

AB - The B cell lymphoma 2 (Bcl-2) family member Bcl-xL has a well-characterized antiapoptotic function in lymphoid cells. However, its functions in other cells - including osteoclasts, which are of hematopoietic origin - and other cellular processes remain unknown. Here we report an unexpected function of Bcl-xL in attenuating the bone-resorbing activity of osteoclasts in mice. To investigate the role of Bcl-xL in osteoclasts, we generated mice with osteoclast-specific conditional deletion of Bcl-x (referred to herein as Bcl-x cKO mice) by mating Bcl-xfl/fl mice with mice in which the gene encoding the Cre recombinase has been knocked into the cathepsin K locus and specifically expressed in mature osteoclasts. Although the Bcl-x cKO mice grew normally with no apparent morphological abnormalities, they developed substantial osteopenia at 1 year of age, which was caused by increased bone resorption. Bcl-x deficiency increased the bone-resorbing activity of osteoclasts despite their high susceptibility to apoptosis, whereas Bcl-xL overexpression produced the opposite effect. In addition, Bcl-x cKO osteoclasts displayed increased c-Src activity, which was linked to increased levels of vitronectin and fibronectin expression. These results suggest that Bcl-xL attenuates osteoclastic bone-resorbing activity through the decreased production of ECM proteins, such as vitronectin and fibronectin, and thus provide evidence for what we believe to be a novel cellular function of Bcl-xL.

UR - http://www.scopus.com/inward/record.url?scp=70349668936&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=70349668936&partnerID=8YFLogxK

U2 - 10.1172/JCI39819

DO - 10.1172/JCI39819

M3 - Article

C2 - 19759519

AN - SCOPUS:70349668936

VL - 119

SP - 3149

EP - 3159

JO - Journal of Clinical Investigation

JF - Journal of Clinical Investigation

SN - 0021-9738

IS - 10

ER -